Hall Brett Matthew
Chief Scientific Officer | Chief Scientific Officer
1 company
Insider Signal Score
53
AverageTrades Analyzed
7
12M Win Rate
50.0%
Avg 3M Return
+33.6%
Avg 12M Return
-0.3%
Hall Brett Matthew is a Chief Scientific Officer at Immuneering Corp. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $1.7M based on current market prices.
Holdings by Company
IMRXJan 15, 2026
Current Shares376.5K
Value$1.67M
Net Activity+27.7K
Bought: 27.7KSold: 0
Transaction History
Showing 6 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | IMRX Immuneering Corp | Chief Scientific Officer | Buy | 2,298 | $4.57 | $10,501.86 | +0.6% | +19.0% | - | |
| Jun 23, 2025 | IMRX Immuneering Corp | Chief Scientific Officer | Buy | 13,422 | $2.58 | $34,616.17 | +1.9% | +257.8% | - | |
| Mar 20, 2024 | IMRX Immuneering Corp | Chief Scientific Officer | Buy | 7,000 | $2.86 | $20,020.00 | +2.1% | -46.8% | -40.6% | |
| May 25, 2022 | IMRX Immuneering Corp | Chief Scientific Officer | Buy | 2,551 | $3.92 | $9,999.92 | +0.8% | +62.7% | +67.9% | |
| Mar 23, 2022 | IMRX Immuneering Corp | Chief Scientific Officer | Buy | 1,050 | $7.91 | $8,305.50 | +0.3% | -39.4% | +35.9% | |
| Aug 3, 2021 | IMRX Immuneering Corp | Chief Scientific Officer | Buy | 1,353 | $15.00 | $20,295.00 | +26.8% | +40.0% | -64.3% |